Nutex Health, Inc.
NASDAQ:NUTX
21.38 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 247.646 | 219.294 | 331.531 | 273.422 | 97.057 | 0.091 | 0.054 | 0 | 0 | 2.549 | 1.266 | 0.22 |
| Cost of Revenue
| 212.872 | 205.842 | 152.25 | 1.82 | 1.661 | 0.062 | 0.564 | 0 | 0.001 | 1.529 | 0.783 | 0.095 |
| Gross Profit
| 34.774 | 13.452 | 179.281 | 271.603 | 95.396 | 0.029 | -0.511 | -0 | -0.001 | 1.019 | 0.483 | 0.126 |
| Gross Profit Ratio
| 0.14 | 0.061 | 0.541 | 0.993 | 0.983 | 0.318 | -9.52 | 0 | 0 | 0.4 | 0.382 | 0.569 |
| Reseach & Development Expenses
| 0 | 0 | 0.286 | 0.557 | 0.768 | 0.545 | 0.026 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 36.066 | 18.031 | 5.462 | 115.129 | 59.869 | 1.164 | 1.814 | 0 | 0 | 1.864 | 1.829 | 0.81 |
| Selling & Marketing Expenses
| 2.836 | 0 | 0.024 | 0.167 | 0.578 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 36.066 | 18.031 | 5.462 | 115.129 | 59.869 | 1.164 | 1.814 | 0.448 | 0.532 | 1.864 | 1.829 | 0.81 |
| Other Expenses
| -0.399 | -0.559 | 5.422 | 5.961 | 2.478 | 0.634 | 3.872 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 36.066 | 18.031 | 5.462 | 121.089 | 62.346 | 1.797 | 5.686 | 0.448 | 0.532 | 1.864 | 1.829 | 0.81 |
| Operating Income
| -1.292 | -5.138 | 170.265 | 152.333 | 34.711 | -1.831 | -5.693 | -0.449 | -0.533 | -0.845 | -1.346 | -0.684 |
| Operating Income Ratio
| -0.005 | -0.023 | 0.514 | 0.557 | 0.358 | -20.034 | -106.118 | 0 | 0 | -0.331 | -1.063 | -3.102 |
| Total Other Income Expenses Net
| -47.199 | -414.511 | -0.774 | -6.775 | -2.621 | -0.984 | 6.275 | -0.002 | -0.003 | 0.029 | 0.008 | 0.004 |
| Income Before Tax
| -48.491 | -419.649 | 169.491 | 145.558 | 32.089 | -2.814 | 0.582 | -0.451 | -0.536 | -0.815 | -1.338 | -0.68 |
| Income Before Tax Ratio
| -0.196 | -1.914 | 0.511 | 0.532 | 0.331 | -30.8 | 10.85 | 0 | 0 | -0.32 | -1.057 | -3.085 |
| Income Tax Expense
| -5.067 | 13.091 | 0.966 | 50.833 | 15.606 | -0.161 | -0.535 | 6.981 | -0.62 | -0.432 | -1.496 | -1.285 |
| Net Income
| -45.787 | -432.74 | 132.593 | 105.97 | 16.483 | -2.814 | 0.582 | -7.432 | 0.084 | -0.383 | 0.158 | 0.605 |
| Net Income Ratio
| -0.185 | -1.973 | 0.4 | 0.388 | 0.17 | -30.8 | 10.85 | 0 | 0 | -0.15 | 0.125 | 2.745 |
| EPS
| -1.05 | -10.24 | 3.36 | 2.68 | 0.4 | -0.039 | 0.014 | -14,045.09 | 1.44 | -0.032 | 0.013 | 0.053 |
| EPS Diluted
| -1.04 | -10.22 | 3.3 | 2.68 | 0.4 | -0.039 | 0.014 | -14,045.09 | 1.44 | -0.032 | 0.013 | 0.053 |
| EBITDA
| 16.3 | 7.994 | 186.903 | 157.952 | 38.097 | -1.831 | -5.693 | -0.448 | -0.532 | -0.845 | -1.346 | -0.684 |
| EBITDA Ratio
| 0.066 | 0.036 | 0.564 | 0.578 | 0.393 | -20.034 | -106.118 | 0 | 0 | -0.331 | -1.063 | -3.102 |